Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells.

Leroux, M E

Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells. [electronic resource] - The Prostate Nov 2007 - 1699-717 p. digital

Publication Type: Journal Article

0270-4137

10.1002/pros.20645 doi


Adenocarcinoma--drug therapy
Apoptosis--drug effects
Cell Line, Tumor
Cell Survival--drug effects
Ceramides--pharmacology
Down-Regulation
Enzyme Inhibitors--pharmacology
Humans
Male
Phosphotransferases (Alcohol Group Acceptor)--antagonists & inhibitors
Prostatic Neoplasms--drug therapy
Proto-Oncogene Proteins c-bcl-2--metabolism
Sphingosine--analogs & derivatives
Thiazoles--pharmacology